These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2443084

  • 21. [On the use of a new drug in the therapy of prostatic adenoma: Tadenan. Clinical considerations on 23 cases].
    Durval A.
    Minerva Urol; 1970; 22(3):106-11. PubMed ID: 4099512
    [No Abstract] [Full Text] [Related]

  • 22. [Use of amino acids as a combination in the treatment of prostatic hypertrophy].
    Menéndez Fernández H, Castillo Vergara P, Hilario García Marcos J, Romero Gil JR.
    Arch Esp Urol; 1988 Sep; 41(7):495-9. PubMed ID: 2468315
    [No Abstract] [Full Text] [Related]

  • 23. Effects of prazosin HCl on the urethral pressure profile in patients with benign prostatic hyperplasia.
    Nakamura K, Kawashita E, Osumi Y, Usui T, Ishibe T.
    Urol Int; 1990 Sep; 45 Suppl 1():30-5. PubMed ID: 1690478
    [Abstract] [Full Text] [Related]

  • 24. [Supplementary drug therapy in the treatment of venous insufficiency. Results of a double-blind study].
    Coninx S.
    Fortschr Med; 1974 Jun 20; 92(18):792-4. PubMed ID: 4605974
    [No Abstract] [Full Text] [Related]

  • 25. [Evaluation of a phytotherapeutic drug in the treatment of urinary incontinence].
    Garza RL, Martínez AS, Barrera CG, González-Pico G, Gutiérrez FG.
    Ginecol Obstet Mex; 1975 May 20; 37(223):287-95. PubMed ID: 1095449
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical test of the new antivaricose agent BayroVas].
    Berger H, Derra A.
    Med Welt; 1972 Apr 08; 23(15):560-3. PubMed ID: 4402616
    [No Abstract] [Full Text] [Related]

  • 27. Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
    Kaplan SA.
    BJU Int; 2008 Nov 08; 102 Suppl 2():3-7. PubMed ID: 19032603
    [No Abstract] [Full Text] [Related]

  • 28. Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
    Jackson G, Rowland M, Adam G, MacFarlane E, Jackson PG.
    Br J Clin Pract; 1986 Jun 08; 40(6):230-4. PubMed ID: 3527246
    [No Abstract] [Full Text] [Related]

  • 29. Medical treatments for benign prostatic hyperplasia and sexual function.
    Giuliano F.
    BJU Int; 2008 Nov 08; 102 Suppl 2():8-12. PubMed ID: 19032604
    [No Abstract] [Full Text] [Related]

  • 30. Prostatic urethral stents.
    Kaplan SA.
    Semin Urol; 1994 Aug 08; 12(3):193-9. PubMed ID: 7527926
    [No Abstract] [Full Text] [Related]

  • 31. [Drug therapy of benign prostatic hyperplasia. Pumpkin et al. in the front line].
    MMW Fortschr Med; 2000 Jul 27; 142(30):53. PubMed ID: 10955026
    [No Abstract] [Full Text] [Related]

  • 32. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH, Shah PJ, Stone R, Choa RG.
    Prog Clin Biol Res; 1981 Jul 27; 78():269-75. PubMed ID: 6174998
    [Abstract] [Full Text] [Related]

  • 33. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD, Mullane JF.
    Clin Ther; 1982 Jul 27; 4(6):497-509. PubMed ID: 7046937
    [Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of Pasta drug, ACESS-A, on gingivitis and marginal periodontitis by a double blind method].
    Murai S, Makino N, Iizuka I, Taguchi T, Okuno K.
    Nihon Shishubyo Gakkai Kaishi; 1982 Sep 27; 24(3):490-515. PubMed ID: 6761402
    [No Abstract] [Full Text] [Related]

  • 35. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA.
    J Urol; 2005 Sep 27; 174(3):1011. PubMed ID: 16094031
    [No Abstract] [Full Text] [Related]

  • 36. [Double-blind controlled study of the therapeutic effectiveness and tolerance of the guabenxan-bemetizid combination as compared with guanethidine-hydrochlorothiazide in arterial hypertension in the aged].
    Silvestrini C, Maini C, Marchesi M, Mueller G.
    G Clin Med; 1982 Apr 27; 63(4):270-8. PubMed ID: 6751915
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical experimentation with V 1326 in prostatic disorders].
    Lange, Muret.
    Bord Med; 1970 Nov 27; 3(11):2807-8 passim. PubMed ID: 4101700
    [No Abstract] [Full Text] [Related]

  • 38. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M, Trucchi E.
    Minerva Urol; 1972 Nov 27; 24(5):167-72. PubMed ID: 4141050
    [No Abstract] [Full Text] [Related]

  • 39. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG.
    BJU Int; 2008 Nov 27; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract] [Full Text] [Related]

  • 40. Role of alpha blockers in the treatment of BPH: a critical review of clinical results.
    Von Heland M, Casale P.
    Arch Esp Urol; 1994 Nov 27; 47(9):873-81; discussion 881-2. PubMed ID: 7530943
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.